HST Global (HSTC) 10-K/A 12 May 14 2013 FY Annual report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
In Millions, except Share data, unless otherwise specified	Dec. 31, 2013	Mar. 31, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'HST Global, Inc.	'
Document Type	'10-K	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'true	'
Entity Central Index Key	'0000797564	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	36,719,854
Entity Public Float	'	$0.10
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'FY	'
Amendment Description	'1	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013		Dec. 31, 2012
Balance Sheets	'		'
Cash and cash equivalents	$230		$1,222
Total Current Assets	230		1,222
Total Assets	230		1,222
Bank overdraft payable	2,360		'
Accounts payable and accrued expenses	5,402		8,563
Accounts payable and accrued expenses - related parties	505,959		505,959
Accrued officer compensation	510,000		390,000
Accrued related party interest	197,889		162,502
Notes payable - related party	1,252,616		1,215,459
Total Current Liabilities	2,474,226		2,282,483
Total Liabilities	2,474,226		2,282,483
Preferred stock	'	[1]	'	[1]
Common stock	36,720	[2]	36,720	[2]
Additional paid-in capital	2,384,824		2,384,824
Deficit accumulated during the development stage	-4,895,540		-4,702,805
Total Stockholders' Deficit	-2,473,996		-2,281,261
Total Liabilities and Stockholders' Deficit	$230		$1,222
[1]	5,000,000 shares authorized, at $0.001 par value, -0- shares issued and outstanding, respectively
[2]	100,000,000 shares authorized, at $0.001 par value, 36,719,854 and 36,719,854 shares issued and outstanding, respectively

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		77 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Statements of Operations	'	'	'
Salaries	'	'	$176,031
Consulting	120,000	120,000	2,321,600
General and administrative expenses	37,348	222,155	1,990,270
Loss on extinguishment of debt - related parties	'	'	160,000
Total Operating Expenses	157,348	342,155	4,647,901
Net Loss From Operations	-157,348	-342,155	-4,647,901
Interest expense	-35,387	-33,768	247,639
Total Other Expenses	35,387	33,768	247,639
Net Loss	($192,735)	($375,923)	($4,895,540)
Net Loss Per Share: Basic And Diluted - Common	($0.01)	($0.01)	'
Weighted Average Shares Outstanding: Basic And Diluted - Common	36,719,854	36,719,854	'

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Deficit (USD $)	Total	Common Stock	Additional Paid-In Capital	Deficit Accumulated during the Development Stage	Total Stockholders' Deficit
Balance Beginning of Period at Aug. 05, 2007	'	'	'	'	'
Common stock issued for cash	'	$2	$1,498	'	$1,500
Common stock issued for cash - Shares	'	1,500	'	'	'
Net Loss	'	'	'	-62,737	-62,737
Balance End of Period at Dec. 31, 2007	'	2	1,498	-62,737	-61,237
Balance End of Period - Shares at Dec. 31, 2007	'	1,500	'	'	'
Recapitalization - reverse acquisition	'	24,030	-40,625	'	-16,595
Recapitalization - reverse acquisition - Shares	'	24,030,353	'	'	'
Common stock issued for cash	'	839	1,048,161	'	1,049,000
Common stock issued for cash - Shares	'	839,200	'	'	'
Common stock issued for services	'	15	142,485	'	142,500
Common stock issued for services - Shares	'	15,000	'	'	'
Net Loss	'	'	'	-1,513,333	-1,513,333
Balance End of Period at Dec. 31, 2008	'	24,886	1,151,519	-1,576,070	-399,665
Balance End of Period - Shares at Dec. 31, 2008	'	24,886,053	'	'	'
Common stock issued for cash	'	341	425,909	'	426,250
Common stock issued for cash - Shares	'	341,086	'	'	'
Common stock issued for services	'	7	7,883	'	7,890
Common stock issued for services - Shares	'	7,000	'	'	'
Net Loss	'	'	'	-1,362,612	-1,362,612
Balance End of Period at Dec. 31, 2009	'	25,234	1,585,311	-2,938,682	-1,328,137
Balance End of Period - Shares at Dec. 31, 2009	'	25,234,139	'	'	'
Common stock issued for services	'	3,486	327,513	'	330,999
Common stock issued for services - Shares	'	3,485,715	'	'	'
Net Loss	'	'	'	-847,850	-847,850
Balance End of Period at Dec. 31, 2010	'	28,720	1,912,824	-3,786,532	-1,844,988
Balance End of Period - Shares at Dec. 31, 2010	'	28,719,854	'	'	'
Common stock issued for services	'	1,000	59,000	'	60,000
Common stock issued for services - Shares	'	1,000,000	'	'	'
Common stock issued for debt	'	7,000	413,000	'	420,000
Common stock issued for debt - Shares	'	7,000,000	'	'	'
Net Loss	'	'	'	-540,350	-540,350
Balance End of Period at Dec. 31, 2011	'	36,720	2,384,824	-4,326,882	-1,905,338
Balance End of Period - Shares at Dec. 31, 2011	'	36,719,854	'	'	'
Net Loss	-375,923	'	'	-375,923	-375,923
Balance End of Period at Dec. 31, 2012	'	36,720	2,384,824	-4,702,805	-2,281,261
Balance End of Period - Shares at Dec. 31, 2012	'	36,719,854	'	'	'
Net Loss	-192,735	'	'	-192,735	-192,735
Balance End of Period at Dec. 31, 2013	'	$36,720	$2,384,824	($4,895,540)	($2,473,996)
Balance End of Period - Shares at Dec. 31, 2013	'	36,719,854	'	'	'

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended		77 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
STATEMENTS OF CASH FLOWS	'	'	'
Net Loss	($192,735)	($375,923)	($4,895,540)
Depreciation and amortization	'	'	2,917
Common stock issued for services	'	'	541,389
Loss on extinguishment of debt - related parties	'	'	160,000
Bank overdraft payable	2,360	'	2,360
Accrued notes payable-related party penalties	'	'	50,000
Accounts payable and accrued expenses	-3,162	-19,839	265,402
Accounts payable and accrued expenses - related parties	'	180,000	505,959
Accrued officer compensation	120,000	120,000	510,000
Accrued related party interest	35,387	33,768	197,889
Net Cash used in Operating Activities	-38,149	-61,994	-2,659,624
Purchase of equipment	'	'	-2,917
Net Cash used in Investing Activities	'	'	-2,917
Proceeds from sale of common stock	'	'	1,476,750
Proceeds from notes payable - related party	37,157	62,760	1,205,652
Repayment on notes payable - related party	'	'	-3,036
Effect of merger adjustment	'	'	-16,595
Net cash provided by financing activities	37,157	62,760	2,662,771
Net Increase (decrease) in cash	-992	766	230
Cash at Beginning of Period	1,222	456	'
Cash at End of Period	230	1,222	230
Common stock issued for debt	'	'	$420,000

Note_1_Organization_and_Princi

Note 1 - Organization and Principal Activities	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 1 - Organization and Principal Activities	'
	NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES
	The Company was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations and was considered a development stage company. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.
	HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases.  In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.

Note_2_Significant_Accounting_

Note 2 - Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 2 - Significant Accounting Policies	'
	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.
	Development Stage Company Classification
	The Company is considered to be in the development stage as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915. This standard requires companies to report their operations, shareholders equity and cash flows from inception through the reporting date. The Company will continue to be reported as a development stage entity until, among other factors, revenues are generated from management’s intended operations. Management has provided financial data since inception (August 6, 2007).
	Accounting Method
	The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected an December 31 year-end.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.
	Income Taxes
	The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, "Income Taxes," which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
	The Company applies the provisions of ASC 740, “Accounting for Uncertainty in Income Taxes”. The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements.  The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.  The Company did not identify any material uncertain tax positions on returns that have been filed or that will be filed.  The Company did not recognize any interest or penalties for unrecognized tax benefits during the years ended December 31, 2013 and 2012, nor were any interest or penalties accrued as of December 31, 2013 and 2012.
	Basic and Diluted Loss Per Share
	The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. The Company had no common stock equivalents outstanding as of December 31, 2013 and 2012.
	Stock-Based Compensation
	The Company adopted ASC 718, “Stock Compensation”, upon inception at August 6, 2007. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of December 31, 2013, the Company has not issued any employer stock options.
	Fair Value of Financial Instruments
	The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.
	The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:
	Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1.
	Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).
	Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.
	Recently Issued Accounting Pronouncements
	Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

Note_3_Going_Concern

Note 3 - Going Concern	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 3 - Going Concern	'
	NOTE 3 – GOING CONCERN
	The Company’s financial statements are prepared using generally accepted accounting principles in the United States of America applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
	Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the money it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely.
	The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Note_5_Accounts_Payable_and_Ac

Note 5 - Accounts Payable and Accrued Expenses - Related Parties	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 5 - Accounts Payable and Accrued Expenses - Related Parties	'
	NOTE 4 – ACCOUNTS PAYABLE AND ACCURED EXPENSES – RELATED PARTIES
	Accounts payable and accrued expenses consist of the following at December 31, 2013 and 2012:
		31-Dec-13	31-Dec-12
	The Health Network, Inc.	$     365,462	$        365,462
	Ronald Howell	43,770	43,770
	Eric Clemons	96,727	96,727
	Total	$     505,959	$        505,959
	Please see Note 6 for further explanation of these liabilities.

Note_6_Notes_Payable_Related_P

Note 6 - Notes Payable - Related Parties	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 6 - Notes Payable - Related Parties	'
	NOTE 5 – NOTES PAYABLE – RELATED PARTIES
	During the year ended December 31, 2013, the Company received $37,157 in additional cash loans from various related parties.
	Total related party notes payable as of December 31, 2013 were $1,252,616.  Of this total, $595,800 of related party notes payable are unsecured, bear interest at 6 percent per annum, and are due on demand. Also of this total, $200,000 is unsecured, bears a flat owed interest amount of $46,000, and is due on demand.  The remaining $406,816 of related party notes payable is unsecured, bears no interest, and is due on demand.
	Included in the related party notes payable balance is a $50,000 penalty fee associated with one of its related party notes due to nonpayment.

Note_7_Related_Party_Transacti

Note 7 - Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 7 - Related Party Transactions	'
	NOTE 6 - RELATED PARTY TRANSACTIONS
	Executive Offices
	The Company's executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. ("THN"), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement.
	The Company currently accrues $0.00 per month as a general operating fee, which covers use of the office space, use of certain equipment, and various other services. At December 31, 2013 and 2012, the Company owes THN an amount of $365,462 and $365,462 respectively, for amounts due under this agreement.
	Consulting Agreements
	The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010.  The consulting agreement may be terminated at will by the Company. The Company intends to continue to engage Mr. Howell as a consultant until his consulting services are no longer required.  As of December 31, 2013 and 2012, the Company owes Mr. Howell $440,000 and $320,000, respectively under the agreement, of which is classified under accrued officer compensation on the balance sheet.
	The Company has entered into a consulting agreement with Eric Clemons, a shareholder of the Company, whereby the Company agreed to pay Mr. Clemons $10,000 per month for consulting services through December 2009. This employment agreement carried the provision that it could be extended beyond this date upon mutual agreement by both parties and that the agreement could be canceled by the Company at any time after that date.  The Company continued to accrue amounts owed under this agreement through July of 2010.  As of December 31, 2013 and 2012, the Company owes Mr. Clemons $70,000 and $70,000, respectively under the agreement, of which is classified under accrued officer compensation on the balance sheet.

Note_8_Stockholders_Deficit

Note 8 - Stockholders' Deficit	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 8 - Stockholders' Deficit	'
	NOTE 7 - STOCKHOLDERS’ DEFICIT
	The Company completed a business combination with Health Source Technologies Inc. on May 9, 2008 (see Note 4). In conjunction with this acquisition the Board of Directors approved a 25 for 1 reverse split of the Company's common stock. Prior to the acquisition the Company had 30,099,203 shares of common stock outstanding. The issuance of the 66,000,000 new shares of common stock to facilitate the business combination gave the company a total of 96,039,203 shares outstanding immediately before the stock split. After the stock split there were 4,041,568 shares outstanding. In addition, the post-acquisition equity structure was to reflect a 95% ownership by the shareholders of Health Source Technologies, Inc. In order to facilitate this structure, an additional 99,744,800 pre-split shares were issued and delivered to HST shareholders once sufficient authorized capital was available. On December 31, 2008, 3,989,792 post split shares were issued. On December 31, 2008, 3,989,792 post split shares were issued to Ron Howell, an officer and shareholder of the Company and Eric Clemons, a shareholder of the Company to complete the terms of the acquisition agreement. These shares have been retroactively reported in the financial statements as being issued in conjunction with the acquisition that occurred on May 5, 2008.
	As part of the consideration for this business combination there were also 1,000,000 shares of preferred stock issued which where convertible into 16.2 (post split) shares of the company's common stock. These preferred shares were converted into 16,200,000 shares of common stock.
	On May 5, 2008, Health Source Technologies, Inc. issued 1,500 shares of common stock for cash at $1.00 per share, for an aggregate total of $1,500.  These shares were exchanged for shares of the Company on May 9, 2008.
	On August 20, 2008, the Company issued 839,200 shares of common stock for cash at $1.25 per share, for an aggregate total of $1,049,000. The Company also issued 15,000 shares of common stock for services at $9.50 per share, for an aggregate total of $142,500.
	On February 20, 2009, the Company issued 60,037 shares of common stock for cash at $1.249 per share, for an aggregate total of $75,000.
	On March 16, 2009, the Company issued 20,012 shares of common stock for cash at $1.249 per share, for an aggregate total of $25,000.
	On June 9, 2009, the Company issued 61,037 shares of common stock for cash at $1.249 per share, for an aggregate total of $76,250.
	On October 28, 2008, the Company issued 200,000 shares of common stock for cash at $1.25 per share, for an aggregate total of $250,000.
	On June 10, 2009, the Company issued 5,000 shares of common stock for services at $1.25 per share, for an aggregate total of $6,250.
	On June 15, 2009, the Company issued 2,000 shares of common stock for services at $0.82 per share, for an aggregate total of $1,640.
	On January 20, 2010, the Company issued 3,185,715 shares of common stock for services at $0.07 per share, for an aggregate total of $223,000.
	On April 23, 2010, the Company issued 150,000 shares of common stock for services at $0.50 per share, for an aggregate total of $75,000.
	On May 20, 2010, the Company issued 150,000 shares of common stock for services at $0.22 per share, for an aggregate total of $32,999.
	On February 2, 2011, the Company issued 1,000,000 shares of common stock for services at $0.06 per share, for an aggregate total of $60,000.
	On February 2, 2011, the Company issued 7,000,000 shares of common stock for settlement of debts.  These shares were valued at $420,000, or $0.06 per share based on the quoted market price of the shares on the date of issuance.

Note_9_Income_Taxes

Note 9 - Income Taxes	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 9 - Income Taxes	'
	NOTE 8 – INCOME TAXES
	The Company follows ASC 740, under which deferred income taxes reflect the net effect of (a) temporary difference between carrying amounts of assets and liabilities for financial purposes and the amounts used for income tax reporting purposes, and (b) net operating loss carry-forwards. No net provision for refundable Federal income tax has been made in the accompanying statement of loss because no recoverable taxes were paid previously. Similarly, no deferred tax asset attributable to the net operating loss carry-forward has been recognized, as it is not deemed likely to be realized.
	The cumulative tax effect at the expected rate of 34 percent of significant items comprising our net deferred tax amount is as follows:
		Year Ended December 31, 2013	Year Ended December 31, 2012
	Income tax benefit attributable to:
	Net operating loss	$        (65,530)	$     (127,814)
	Common stock issued for services	-	-
	Change in valuation allowance	65,530	127,814
	Net refundable amount	$                     -	$                    -
	The cumulative tax effect at the expected rate of 34 percent of significant items comprising our net deferred tax amount is as follows:
		31-Dec-13	31-Dec-12
	Deferred tax asset attributable to:
	Net operating loss carry forwards	$   (1,699,118)	$   (1,633,588)
	Common stock issued for services	184,072	184,072
	Valuation allowance	1,515,045	1,449,516
	Net deferred tax asset	$                      -	$                      -
	The Company’s zero percent effective tax rate for each year, as compared to the 34 percent statutory rate, results from non-deductible stock based compensation and the change in valuation allowance.
	At December 31, 2013, the Company had an unused net operating loss carry-forward of approximately $(1,699,118) that is available to offset future taxable income; the loss carry-forward will begin to expire in 2027.

Note_10_Subsequent_Events

Note 10 - Subsequent Events	12 Months Ended
	Dec. 31, 2013
Notes	'
Note 10 - Subsequent Events	'
	NOTE 9 – SUBSEQUENT EVENTS
	In accordance with ASC 855, Company management reviewed all material events through the date of this report and determined that there are no material subsequent events to report.

Note_2_Significant_Accounting_1

Note 2 - Significant Accounting Policies: Basis of Presentation (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.

Note_2_Significant_Accounting_2

Note 2 - Significant Accounting Policies: Development Stage Company Classification (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Development Stage Company Classification	'
	Development Stage Company Classification
	The Company is considered to be in the development stage as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 915. This standard requires companies to report their operations, shareholders equity and cash flows from inception through the reporting date. The Company will continue to be reported as a development stage entity until, among other factors, revenues are generated from management’s intended operations. Management has provided financial data since inception (August 6, 2007).

Note_2_Significant_Accounting_3

Note 2 - Significant Accounting Policies: Accounting Method (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Accounting Method	'
	Accounting Method
	The Company’s financial statements are prepared using the accrual method of accounting.  The Company has elected an December 31 year-end.

Note_2_Significant_Accounting_4

Note 2 - Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Note_2_Significant_Accounting_5

Note 2 - Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

Note_2_Significant_Accounting_6

Note 2 - Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes in accordance with accounting guidance now codified as FASB ASC 740, "Income Taxes," which requires that the Company recognize deferred tax liabilities and assets based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities, using enacted tax rates in effect in the years the differences are expected to reverse. Deferred income tax benefit (expense) results from the change in net deferred tax assets or deferred tax liabilities. A valuation allowance is recorded when it is more likely than not that some or all deferred tax assets will not be realized.
	The Company applies the provisions of ASC 740, “Accounting for Uncertainty in Income Taxes”. The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements.  The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.  The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.  The Company did not identify any material uncertain tax positions on returns that have been filed or that will be filed.  The Company did not recognize any interest or penalties for unrecognized tax benefits during the years ended December 31, 2013 and 2012, nor were any interest or penalties accrued as of December 31, 2013 and 2012.

Note_2_Significant_Accounting_7

Note 2 - Significant Accounting Policies: Basic Loss Per Share (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Basic Loss Per Share	'
	Basic and Diluted Loss Per Share
	The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is antidilutive. The Company had no common stock equivalents outstanding as of December 31, 2013 and 2012.

Note_2_Significant_Accounting_8

Note 2 - Significant Accounting Policies: Stock-based Compensation (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Stock-based Compensation	'
	Stock-Based Compensation
	The Company adopted ASC 718, “Stock Compensation”, upon inception at August 6, 2007. Under ASC 718, all share-based payments to employees, including grants of employee stock options, are to be recognized in the income statement based on their fair values. As of December 31, 2013, the Company has not issued any employer stock options.

Note_2_Significant_Accounting_9

Note 2 - Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The Company adopted ASC 820 which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements and the related disclosures. Under this standard certain assets and liabilities must be measured at fair value, and disclosures are required for items measured at fair value.
	The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. The Company’s financial assets and liabilities are measured using inputs from the three levels of the fair value hierarchy. The three levels are as follows:
	Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. The fair value of the Company’s cash is based on quoted prices and therefore classified as Level 1.
	Level 2 - Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates, yield curves, etc.), and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market corroborated inputs).
	Level 3 - Unobservable inputs that reflect our assumptions about the assumptions that market participants would use in pricing the asset or liability.

Recovered_Sheet1

Note 2 - Significant Accounting Policies: Recently Issued Accounting Pronouncements (Policies)	12 Months Ended
	Dec. 31, 2013
Policies	'
Recently Issued Accounting Pronouncements	'
	Recently Issued Accounting Pronouncements
	Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s consolidated financial statements.

Note_5_Accounts_Payable_and_Ac1

Note 5 - Accounts Payable and Accrued Expenses - Related Parties: Schedule of Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Accounts Payable and Accrued Liabilities	'
		31-Dec-13	31-Dec-12
	The Health Network, Inc.	$     365,462	$        365,462
	Ronald Howell	43,770	43,770
	Eric Clemons	96,727	96,727
	Total	$     505,959	$        505,959

Note_9_Income_Taxes_Schedule_o

Note 9 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Deferred Tax Assets and Liabilities	'
		Year Ended December 31, 2013	Year Ended December 31, 2012
	Income tax benefit attributable to:
	Net operating loss	$        (65,530)	$     (127,814)
	Common stock issued for services	-	-
	Change in valuation allowance	65,530	127,814
	Net refundable amount	$                     -	$                    -
	The cumulative tax effect at the expected rate of 34 percent of significant items comprising our net deferred tax amount is as follows:
		31-Dec-13	31-Dec-12
	Deferred tax asset attributable to:
	Net operating loss carry forwards	$   (1,699,118)	$   (1,633,588)
	Common stock issued for services	184,072	184,072
	Valuation allowance	1,515,045	1,449,516
	Net deferred tax asset	$                      -	$                      -

Note_5_Accounts_Payable_and_Ac2

Note 5 - Accounts Payable and Accrued Expenses - Related Parties: Schedule of Accounts Payable and Accrued Liabilities (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
The Health Network, Inc.	$365,462	$365,462
Ronald Howell	43,770	43,770
Eric Clemons	96,727	96,727
Accounts Payable and Accrued Liabilities	$505,959	$505,959

Note_6_Notes_Payable_Related_P1

Note 6 - Notes Payable - Related Parties (Details) (USD $)	12 Months Ended		77 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
Details	'	'	'
Proceeds from notes payable - related party	$37,157	$62,760	$1,205,652
Notes Payable, Related Parties	1,252,616	'	1,252,616
Notes Payable with Annual Interest	595,800	'	595,800
Notes Payable with Flat Interest	200,000	'	200,000
Flat Interest Payable	46,000	'	46,000
Notes Payable with No Interest	406,816	'	406,816
Related Party Notes Penalties Payable	$50,000	'	$50,000

Note_7_Related_Party_Transacti1

Note 7 - Related Party Transactions (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Ron Howell Consulting Agreement	$440,000	$320,000
Accrued Consulting Fee	$70,000	$70,000

Note_8_Stockholders_Deficit_De

Note 8 - Stockholders' Deficit (Details) (USD $)

0 Months Ended

1 Months Ended

77 Months Ended

Feb. 02, 2011

20-May-10

Apr. 23, 2010

Jan. 20, 2010

Jun. 15, 2009

Jun. 10, 2009

Jun. 09, 2009

Mar. 16, 2009

Feb. 20, 2009

Oct. 28, 2008

Aug. 20, 2008

5-May-08

Dec. 31, 2008

31-May-08

Dec. 31, 2013

9-May-08

8-May-08

Details

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common Stock, Shares, Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,041,568

30,099,203

Stock Issued During Period, Shares, Acquisitions

'

'

'

'

'

'

'

'

'

'

'

'

'

66,000,000

'

'

'

Common Stock Shares Outstanding Pre-Split

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

96,039,203

Common Stock Shares Issuable Pre-Split

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

99,744,800

'

Common Stock Shares Issued to THN Shareholders

'

'

'

'

'

'

'

'

'

'

'

'

3,989,792

'

'

'

'

Common Stock Shares Issued to THN Officers

'

'

'

'

'

'

'

'

'

'

'

'

3,989,792

'

'

'

'

Preferred Stock Shares Issued During the Period

'

'

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

Conversion of Stock, Shares Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

16,200,000

'

'

'

Stock Issued During Period, Shares, Issued for Cash

'

'

'

'

'

'

61,037

20,012

60,037

200,000

839,200

1,500

'

'

'

'

'

Stock Issued During Period, Value, Issued for Cash

'

'

'

'

'

'

$76,250

$25,000

$75,000

$250,000

$1,049,000

$1,500

'

'

'

'

'

Common stock issued for services - Shares

1,000,000

150,000

150,000

3,185,715

2,000

5,000

'

'

'

'

15,000

'

'

'

'

'

'

Common stock issued for services

60,000

32,999

75,000

223,000

1,640

6,250

'

'

'

'

142,500

'

'

'

541,389

'

'

Common stock issued for debt - Shares

7,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued for debt

$420,000

'

'

'

'

'

'

'

'

'

'

'

'

'

$420,000

'

'

Note_9_Income_Taxes_Schedule_o1

Note 9 - Income Taxes: Schedule of Deferred Tax Assets and Liabilities (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Income Tax Reconciliation, Income Tax Expense (Benefit), at Federal Statutory Income Tax Rate	($65,530)	($127,814)
Income Tax Reconciliation, Change in Deferred Tax Assets Valuation Allowance	65,530	127,814
Deferred Tax Assets, Operating Loss Carryforwards	-1,699,118	-1,633,588
Deferred Tax Assets, Other	184,072	184,072
Deferred Tax Assets, Valuation Allowance	$1,515,045	$1,449,516

Note_9_Income_Taxes_Details

Note 9 - Income Taxes (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Deferred Tax Assets, Operating Loss Carryforwards	($1,699,118)	($1,633,588)